ACOUSORT AB BTAACOUSORT AB BTAACOUSORT AB BTA

ACOUSORT AB BTA

No trades
See on Supercharts
Market capitalization
‪56.64 M‬SEK
−1.01SEK
‪−15.08 M‬SEK
‪4.74 M‬SEK
‪5.27 M‬
Beta (1Y)

About ACOUSORT AB


CEO
Torsten Freltoft
Headquarters
Lund
Founded
2010
ISIN
SE0024517981
FIGI
BBG01SQ5R757
AcouSort AB engages in the provision of biotechnology. It offers solutions for automated sample preparations involving biological cells or other organelles. The firm's activities include development and commercialization of proprietary bioanalytical and clinical applications based on acoustophoresis including AcouTrap, AcouPlasma, and AcouWash. The company was founded by Lars Thomas Laurell, Patrik Brundin, Hans Lilja, and Stefan Scheding in December 2010 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

Check out other big names from the same industry as ACOU_BTA.

Frequently Asked Questions


The current price of ACOU_BTA is 3.18 SEK — it has decreased by −10.27% in the past 24 hours. Watch ACOUSORT AB BTA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ACOUSORT AB BTA stocks are traded under the ticker ACOU_BTA.
ACOU_BTA stock has fallen by −14.87% compared to the previous week, the month change is a −14.87% fall, over the last year ACOUSORT AB BTA has showed a −18.46% decrease.
Today ACOUSORT AB BTA has the market capitalization of ‪52.16 M‬, it has increased by 5.26% over the last week.
Yes, you can track ACOUSORT AB BTA financials in yearly and quarterly reports right on TradingView.
ACOU_BTA net income for the last quarter is ‪−2.83 M‬ SEK, while the quarter before that showed ‪−3.81 M‬ SEK of net income which accounts for 25.69% change. Track more ACOUSORT AB BTA financial stats to get the full picture.
No, ACOU_BTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACOUSORT AB BTA EBITDA is ‪−21.18 M‬ SEK, and current EBITDA margin is −447.22%. See more stats in ACOUSORT AB BTA financial statements.
Like other stocks, ACOU_BTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACOUSORT AB BTA stock right from TradingView charts — choose your broker and connect to your account.